Boots Paracetamol 500 mg tablets (16s)
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 2 recall · DMRC-34874518
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Boots Paracetamol 500 mg tablets (16s) | PL 08977/0001 | paracetamol |
Background: Aspar Pharmaceuticals Limited have informed the MHRA of an error related to Boots Paracetamol 500 mg tablets (16s), a product manufactured by Aspar Pharmaceuticals Limited and distributed by The Boots Company PLC. Following a customer complaint, it was identified that the foil blister inside the carton of Paracetamol 500 mg tablets (16s), incorrectly states ‘Aspirin 300 mg Dispersible Tablets’. Aspar pharmaceuticals have retrieved and inspected the reported batch and confirmed that the tablets in the blister packs are Paracetamol 500 mg tablets. This batch was first distributed on 14/01/2025 and any customers or patients who have purchased the product should return the packs to Boots stores for a full refund, with or without a receipt. The impacted batch is only sold in Boots stores and Boots online pharmacy and does not impact any other products or batches that share the same PL num